|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 HKD | -2.86% |
|
-1.16% | -24.78% |
| Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
| Mar. 20 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
JW (Cayman) Therapeutics Co. Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 173.86 million compared to CNY 145.7 million a year ago.
Net loss was CNY 768 million compared to CNY 846.14 million a year ago. Basic loss per share from continuing operations was CNY 1.87 compared to CNY 2.06 a year ago. Diluted loss per share from continuing operations was CNY 1.87 compared to CNY 2.06 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.78% | 87.63M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
JW (CAYMAN) THERAPEUTICS CO. LTD 
